Search Results - "RAVE, Klaus"

Time-Action Profile of Inhaled Insulin in Comparison With Subcutaneously Injected Insulin Lispro and Regular Human Insulin by Rave, Klaus, Bott, Susanne, Heinemann, Lutz, Sha, Sue, Becker, Reinhard H.A, Willavize, Susan A, Heise, Tim

“…OBJECTIVE:--This study compares the time-action profile of inhaled insulin (INH; Exubera) with that of subcutaneously injected insulin lispro (ILP) or regular…”
Get full text

Advantage of Premeal-Injected Insulin Glulisine Compared With Regular Human Insulin in Subjects With Type 1 Diabetes by Rave, Klaus, Klein, Oliver, Frick, Annke D, Becker, Reinhard H.A

“…OBJECTIVE:--Insulin glulisine, a rapid-acting insulin analog, provides prandial insulin replacement. In this study, we compared postprandial blood glucose…”
Get full text

Pharmacokinetics, Prandial Glucose Control, and Safety of Insulin Glulisine in Children and Adolescents With Type 1 Diabetes by Danne, Thomas, Becker, Reinhard H. A, Heise, Tim, Bittner, Claudia, Frick, Annke D, Rave, Klaus

“…OBJECTIVE:--The aim of this study was to investigate the pharmacokinetics, postprandial blood glucose excursions, and safety of insulin glulisine as compared…”
Get full text

Dose Response of Inhaled Dry-Powder Insulin and Dose Equivalence to Subcutaneous Insulin Lispro by Rave, Klaus M, Nosek, Leszek, de la Peña, Amparo, Seger, Mary, Ernest, Charles S, Heinemann, Lutz, Batycky, Richard P, Muchmore, Douglas B

“…OBJECTIVE:--To determine the pharmacokinetic (PK) and glucodynamic (GD) dose response of human insulin inhalation powder (HIIP) delivered via AIR particle…”
Get full text

Impact of Diabetic Nephropathy on Pharmacodynamic and Pharmacokinetic Properties of Insulin in Type 1 Diabetic Patients by Rave, K, Heise, T, Pfützner, A, Heinemann, L, Sawicki, P T

“…Impact of Diabetic Nephropathy on Pharmacodynamic and Pharmacokinetic Properties of Insulin in Type 1 Diabetic Patients Klaus Rave 1 , Tim Heise 1 , Andreas…”
Get full text

AIR Inhaled Insulin in Subjects With Chronic Obstructive Pulmonary Disease by Rave, Klaus, de la Peña, Amparo, Tibaldi, Fabián S., Zhang, Liping, Silverman, Bernard, Hausmann, Michaela, Heinemann, Lutz, Muchmore, Douglas B.

“…AIR Inhaled Insulin in Subjects With Chronic Obstructive Pulmonary Disease Pharmacokinetics, glucodynamics, safety, and tolerability Klaus Rave , MD 1 , Amparo…”
Get full text

Value of blood pressure self-monitoring as a predictor of progression of diabetic nephropathy by Rave, Klaus, Bender, Ralf, Heise, Tim, Sawicki, Peter T

“…OBJECTIVETo determine the impact of self-monitoring of blood pressure values (BPS) as compared with office blood pressure measurements (BPO) on the progression…”
Get full text

Further Improvement in Postprandial Glucose Control With Addition of Exenatide or Sitagliptin to Combination Therapy With Insulin Glargine and Metformin: A proof-of-concept study by Arnolds, Sabine, Dellweg, Sibylle, Clair, Janina, Dain, Marie-Paule, Nauck, Michael A, Rave, Klaus, Kapitza, Christoph

“…OBJECTIVE: To assess the effect of a 4-week adjunctive therapy of exenatide (EXE) (5-10 μg b.i.d.) or sitagliptin (SITA) (100 mg once daily) in response to a…”
Get full text

Basal insulin glargine vs prandial insulin lispro in type 2 diabetes by Arnolds, Sabine, Rave, Klaus

Get full text

An analysis of how to measure glucose during glucose clamps: are glucose meters ready for research? by Hompesch, Marcus, Rave, Klaus

“…This article provides a perspective on the challenges of appropriate glucose measurement in the context of glucose clamp experiments. In a first step, the core…”
Get full text

Improvement of insulin resistance after diet with a whole-grain based dietary product: results of a randomized, controlled cross-over study in obese subjects with elevated fasting blood glucose by Rave, Klaus, Roggen, Kerstin, Dellweg, Sibylle, Heise, Tim, tom Dieck, Heike

“…Subjects with obesity and elevated fasting blood glucose are at high risk of developing type 2 diabetes which may be reduced by a dietary intervention leading…”
Get full text

Arsenite and Arsenate Adsorption on Ferrihydrite:  Kinetics, Equilibrium, and Adsorption Envelopes by Raven, Klaus P, Jain, Amita, Loeppert, Richard H

“…Because of its toxicity, arsenic is of considerable environmental concern. Its solubility in natural systems is strongly influenced by adsorption at iron oxide…”
Get full text

Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo by HEINEMANN, L, LINKESCHOVA, R, RAVE, K, HOMPESCH, B, SEDLAK, M, HEISE, T

“…Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo. L Heinemann , R…”
Get full text

Renal glucose excretion as a function of blood glucose concentration in subjects with type 2 diabetes—results of a hyperglycaemic glucose clamp study by Rave, Klaus, Nosek, Leszek, Posner, John, Heise, Tim, Roggen, Kerstin, van Hoogdalem, Ewoud-Jan

“…Background. The purpose of this study was to investigate renal glucose excretion as a function of blood glucose concentration and to evaluate the…”
Get full text

Coverage of postprandial blood glucose excursions with inhaled technosphere insulin in comparison to subcutaneously injected regular human insulin in subjects with type 2 diabetes by RAVE, Klaus, PFUTZNER, Andreas, HEISE, Tim, BOSS, Anders H

“…Primary efficacy variables, all baseline adjusted, were area under the curve (AUC) of postprandial blood glucose excursion (BG-AUC^sub 0_240min^), maximum…”
Get full text

Effect of the urotensin‐II receptor antagonist palosuran on secretion of and sensitivity to insulin in patients with Type 2 diabetes mellitus by Sidharta, Patricia N., Rave, Klaus, Heinemann, Lutz, Chiossi, Eleonora, Krähenbühl, Stephan, Dingemanse, Jasper

“…WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • Urotensin‐II (U‐II) is one of the most potent vasoconstrictors identified thus far. • Although differences in both…”
Get full text

Further Improvement in Postprandial Glucose Control With Addition of Exenatide or Sitagliptin to Combination Therapy With Insulin Glargine and Metformin by Arnolds, Sabine, Dellweg, Sibylle, Clair, Janina, Dain, Marie-Paule, Nauck, Michael A., Rave, Klaus, Kapitza, Christoph

“…OBJECTIVE To assess the effect of a 4-week adjunctive therapy of exenatide (EXE) (5–10 μg b.i.d.) or sitagliptin (SITA) (100 mg once daily) in response to a…”
Get full text

Dose-Response Relationship of Insulin Glulisine in Subjects With Type 1 Diabetes by Becker, Reinhard H.A, Frick, Annke D, Nosek, Leszek, Heinemann, Lutz, Rave, Klaus

Get full text

AIR Inhaled Insulin in Subjects With Chronic Obstructive Pulmonary Disease: Pharmacokinetics, glucodynamics, safety, and tolerability by Rave, Klaus, de la Peña, Amparo, Tibaldi, Fabián S, Zhang, Liping, Silverman, Bernard, Hausmann, Michaela, Heinemann, Lutz, Muchmore, Douglas B

“…OBJECTIVE:-- In this open-label, randomized, crossover study, pharmacokinetic and glucodynamic responses were compared in healthy subjects versus subjects with…”
Get full text

First-phase insulin secretion has limited impact on postprandial glycemia in subjects with type 2 diabetes: correlations between hyperglycemic glucose clamp and meal test by Rave, Klaus, Sidharta, Patricia N, Dingemanse, Jasper, Heinemann, Lutz, Roggen, Kerstin

“…Lack of first-phase insulin (INS) secretion is regarded as causative for high postprandial glucose excursions in subjects with type 2 diabetes. We aimed to…”
Get more information